Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail)

v3.23.1
NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail) - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Common stock issued under the Backstop Agreement    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 9,600,031 9,600,031
Restricted stock grants with only service conditions    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 4,529,117 3,108,277
Private placement warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 272,779 272,779